Published in
Taylor and Francis Group, Expert Opinion on Investigational Drugs, 12(30), p. 1209-1219, 2021
DOI: 10.1080/13543784.2022.2022119
Links
Tools
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes
Journal article published in 2021 by
Carmen Mignogna,
Ernesto Maddaloni,
Luca D’Onofrio 
,
Raffaella Buzzetti
,
Raffaella Buzzetti
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 